Red flags / Going concern
Passage Bio flags substantial doubt about going concern as cash may not cover next twelve months
Passage Bio's 10-Q for the period ended September 30, 2026 states that its $20.2 million in cash and cash equivalents may not be sufficient to fund operating and capital expenditure needs for at least the next twelve months. The company reports net losses of $4.7 million for the quarter and $20.1 million for the nine months, and says its ability to continue depends on completing the proposed Merger and related Concurrent Financing or obtaining other substantial funding. Dilution, costly transactions and uncertain financing terms are cited as risks that can weigh on shareholders.
“As a result, substantial doubt exists about our ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.”
What the stock did
From the last close before the filing was public. Market cap now: $13M.
10-K or 10-Q says there is substantial doubt the company can keep operating. Flags are a screen for filings worth reading, not advice. Read the filing before acting on it.
Other flags on PASG
| Filed | Stock | Flag | What the filing says | Mkt cap | 5 days | 20 days |
|---|---|---|---|---|---|---|
| Nov 18, 4:15 PM ET | PASG Passage Bio Inc. | Delisting notice ElevatedForm 8-K | Passage Bio receives Nasdaq notice for stockholders' equity deficiency, plans merger with Remix to cure | $13M | - | - |